8490
A. Goel et al. / Tetrahedron Letters 46 (2005) 8487–8491
Lee, H. J.;Rhee, I. K.;Lee, K. B.;Yoo, I. D.;Song, K. S.
J. Antibiot. 2000, 53, 714–719;(e) Yun, B. S.;Lee, I. K.;
Kim, J. P.;Yoo, I. D. J. Antibiot. 2000, 53, 114–122.
25. Ho¨gberg, T.;Vora, M.;Drake, S. D.;Mitscher, L. A.;
Chu, D. T. W. Acta Chem. Scand. B 1984, 38, 359–366.
26. Wu, C.-J. J.;Xue, C.;Kuo, Y.-M.;Luo, F.-T. Tetrahedron
2005, 61, 4735–4741.
27. (a) Greenham, N. C.;Moratti, S. C.;Bradley, D. D. C.;
Friend, R. H.;Holmes, A. B. Nature 1993, 365, 628–630;
(b) Moratti, S. C.;Cervini, R.;Holmes, A. B.;Baigent,
2. Tsukamo, S.;Macabalang, A. D.;Abe, T.;Hirota, H.;
Ohta, T. Tetrahedron 2002, 58, 1103–1105.
3. (a) Kurobane, I.;Vining, L. C.;McInnes, A. G.;Smith, D.
G. J. Antibiot. 1979, 32, 559–564;(b) Takahashi, C.;
Yoshihira, K.;Natori, S.;Umeda, M. Chem. Pharm. Bull.
1976, 24, 613–620.
D. R.;Friend, R. H.;Greenham, N. C.;Gru
ner, J.;
¨
Hamer, P. J. Synth. Met. 1995, 71, 2117–2120.
4. Nakagawa, F.;Enokita, R.;Naito, A.;Iijima, Y.;Yama-
zaki, M. J. Antibiot. 1984, 37, 6–9.
28. General procedure for the synthesis of 3 and 4: A mixture
of 6-aryl-3-methoxycarbonyl-4-methylsulfanyl-2H-pyran-
2-one 1 (1 mmol), 2-methoxyacetophenone 2 (1.1 mmol)
and powdered KOH (1.2 mmol) in dry DMF (5 mL) was
stirred at room temperature for 9–12 h. The reaction
mixture was poured into ice water with vigorous stirring
and neutralized with dilute HCl. The solid thus obtained
was filtered and pure compounds were isolated by passing
through a silica gel column using chloroform–hexane (1:2)
as eluent;Compound 3a: white solid;yield 62%;mp 146–
148 °C; 1H NMR (200 MHz, CDCl3) d 2.50 (s, 3H, SCH3),
3.06 (s, 3H, OCH3), 3.56 (s, 3H, COOCH3), 7.37–7.48 (m,
5. (a) Stead, P.;Affleck, K.;Sidebottom, P. J.;Taylor, N. L.;
Drake, C. S.;Todd, M.;Jowett, A.;Webb, G. J Antibiot.
1999, 52, 89–95;(b) Kamigauchi, T.;Sakazaki, R.;
Nagashima, K.;Kawamura, Y.;Yasuda, Y.;Matsushima,
K.;Tani, H.;Takahashi, Y.;Ishii, K.;Suzuki, R.;
Koizumi, K.;Nakai, H.;Ikenishi, Y.;Terui, Y. J. Antibiot.
1998, 51, 445–450.
6. Sutton, A. E.;Clardy, J. Tetrahedron Lett. 2001, 42, 547–
551.
7. Chakraborty, S.;Sengupta, C.;Roy, K.
Bioorg. Med.
ꢀ1
Chem. Lett. 2004, 14, 4665–4670.
9H, ArH), 7.56–7.61 (m, 2H, ArH);IR (KBr) 1736 cm
8. (a) von Geldern, T. W.;Brun, R. P.;Kalmanovich, M.;
Wilcox, D.;Jacobson, P. B. Synlett 2004, 1446–1448;(b)
Greenfield, A. A.;Butera, J. A.;Caufield, C. E. Tetra-
hedron Lett. 2003, 44, 2729–2732, and references cited
therein.
9. Yamazoe, A.;Hayashi, K.;Kuboki, A.;Ohira, S.;Nozaki,
H. Tetrahedron Lett. 2004, 45, 8359–8362.
10. (a) Bordat, P.;Brown, R. Chem. Phys. Lett. 2000, 331,
439–445;(b) Fabian, W. M. F.;Kauffman, J. M. J. Lumin.
1999, 85, 137–148.
11. (a) Schiavon, G.;Zecchin, S.;Zotti, G.;Cattarin, S. J.
Electroanal. Chem. 1986, 213, 53–64;(b) Berlman, I. B.;
Wirth, H. O.;Steingraber, O. J. J. Phys. Chem. 1971, 75,
318–325;(c) Maya, F.;Tour, J. M. Tetrahedron 2004, 60,
81–92.
12. (a) Wright, R. S.;Vinod, T. K. Tetrahedron 2003, 44,
7129–7132;(b) Watanabe, S.;Goto, K.;Kawashima, T.;
Okazaki, R. Tetrahedron Lett. 1995, 36, 7677–7680;(c)
Rajakumar, P.;Srisailas, M. Tetrahedron 2003, 59, 5373–
5376.
(CO);MS (FAB) 364 (M +);Anal. Calcd for C 22H20O3S:
C, 72.5;H, 5.5%. Found: C, 72.2;H, 5.9%. Compound
3b: White solid;yield 58%;mp 106–108 °C; 1H NMR
(200 MHz, CDCl3) d 2.32 (s, 3H, CH3), 2.40 (s, 3H,
SCH3), 2.98 (s, 3H, OCH3), 3.46 (s, 3H, COOCH3), 7.14–
ꢀ1
7.43 (m, 10H, ArH);IR (KBr) 1730 cm
(CO);MS
(FAB) 378 (M+). Compound 3c: White solid;yield 56%;
mp 148–150 °C; 1H NMR (200 MHz, CDCl3) d 2.50 (s,
3H, SCH3), 3.06 (s, 3H, OCH3), 3.55 (s, 3H, COOCH3),
7.34 (s, 1H, ArH), 7.36–7.40 (m, 5H, ArH), 7.47 (d, 2H,
J = 8.4 Hz, ArH), 7.57 (d, 2H, J = 8.4 Hz, ArH);IR
(KBr) 1727 cmꢀ1 (CO);MS (FAB) 444 (M ++2), 442 (M+).
Compound 3d: White solid;yield 60%;mp 154–156 °C; 1H
NMR (200 MHz, CDCl3) d 2.50 (s, 3H, SCH3), 3.06 (s,
3H, OCH3), 3.55 (s, 3H, COOCH3), 7.34–7.43 (m, 8H,
ArH), 7.51–7.56 (m, 2H, ArH);IR (KBr) 1727 cm ꢀ1 (CO);
MS (FAB) 398 (M+). Compound 4a: Yellow solid;yield
18%;mp 260–262 °C; 1H NMR (200 MHz, CDCl3) d 3.69
(s, 3H, OCH3), 7.07 (s, 1H, CH), 7.48–7.60 (m, 6H, ArH),
7.96–8.04 (m, 2H, ArH), 8.00–8.20 (m, 2H, ArH);IR
(KBr) 1703, 1793 cmꢀ1 (CO);MS (FAB) 347 (M ++1);
Anal. Calcd for C21H14O5: C, 72.8;H, 4.0%. Found: C,
72.3;H, 4.0%. Compound 4b: Yellow solid;yield 14%;mp
´
13. Hassan, J.;Se vignon, M.;Gozzi, C.;Schulz, E.;Lemaire,
M. Chem. Rev. 2002, 102, 1359–1469.
14. Miyaura, N.;Suzuki, A. Chem. Rev. 1995, 95, 2457–
2483.
15. Todd, M. H.;Balasubramanian, S.;Abell, C. Tetrahedron
Lett. 1997, 38, 6781–6784.
1
219–220 °C; H NMR (200 MHz, CDCl3) d 2.45 (s, 3H,
CH3), 3.69 (s, 3H, OCH3), 7.01 (s, 1H, CH), 7.33 (d, 2H,
J = 8.0 Hz, ArH), 7.36–7.54 (m, 3H, ArH), 7.89 (d, 2H,
J = 8.0 Hz, ArH), 8.10–8.14 (m, 2H, ArH);IR (KBr)
1710, 1779 cmꢀ1 (CO);MS (FAB) 361 (M ++1). Com-
pound 4c: Yellow solid;yield 13%;mp 248–250 °C; 1H
NMR (200 MHz, CDCl3) d 3.69 (s, 3H, OCH3), 7.05 (s,
1H, CH), 7.50–7.56 (m, 3H, ArH), 7.68 (d, 2H, J = 8.6 Hz,
ArH), 7.87 (d, 2H, J = 8.6 Hz, ꢀA1rH), 8.10–8.16 (m, 2H,
ꢀ
16. Corsico, E. F.;Rossi, R. A. Synlett 2000, 230–232.
17. Sharp, M. J.;Cheng, W.;Snieckus, V. Tetrahedron Lett.
1987, 28, 5093–5096.
18. (a) Greenfield, A. A.;Butera, J. A.;Caufield, C. E.
Tetrahedron Lett. 2003, 44, 2729–2732;(b) Zim, D.;
Lando, V. R.;Dupont, J.;Monteiro, A. L.
Org. Lett.
2001, 3, 3049–3051.
ArH);IR (KBr) 1718, 1769 cm
(CO);MS (FAB) 427,
19. (a) Borner, R. C.;Jackson, R. F. W. J. Chem. Soc., Chem.
Commun. 1994, 845;(b) Rottla ¨nder, M.;Knochel, P.
J. Org. Chem. 1998, 63, 203–208.
20. Tominaga, Y.;Ushirogochi, A.;Matsuda, Y. J. Hetero-
cycl. Chem. 1987, 24, 1557–1567.
21. Creak, G. A.;Lewis, S. E.;Tan, S. F. J. Singapore Natl.
Acad. Sci. 1973, 3, 223–226.
22. Nokolov, P.;Dimitrova, E.;Petkov, I.;Anghelova, Y.;
Markov, P. Bulg. Acad. Sci., Bulg. 1994, 81, 5–12.
23. Nikolov, P.;Petkov, I.;Markov, P. Z. Naturforsc. A: Phys.
Sci. 2000, 741–744.
425 (M++1). Compound 4d: Yellow solid;yield 18%;mp
1
258–260 °C; H NMR (200 MHz, CDCl3) d 3.69 (s, 3H,
OCH3), 7.04 (s, 1H, CH), 7.48–7.56 (m, 5H, ArH), 7.95 (d,
2H, J = 8.4 Hz, ArH), 8.11–8.16 (m, 2H, ArH);IR (KBr)
1721, 1770 cmꢀ1 (CO);MS (FAB) 383, 381 (M ++1).
Compound 6a: White solid;yield 74%;mp 150–152 °C; 1H
NMR (200 MHz, CDCl3) d 1.58–1.64 (m, 2H, CH2), 1.73–
1.82 (m, 4H, 2CH2), 3.03 (s, 3H, OCH3), 3.12–3.18 (m,
4H, 2CH2), 6.99 (s, 1H, ArH), 7.38–7.61 (m, 10H, ArH);
IR (KBr) 2217 cmꢀ1 (CN);MS (FAB) 368 (M +);Anal.
Calcd for C25H24N2O: C, 81.4;H, 6.5;N, 7.6%. Found: C,
81.0;H, 6.7;N, 7.5%. Compound 6b: White solid;yield
84%;mp 108–110 °C; 1H NMR (200 MHz, CDCl3) d
1.57–1.63 (m, 2H, CH2), 1.73–1.83 (m, 4H, 2CH2), 2.40 (s,
24. (a) Ikekawa, T.;Uehara, N.;Maeda, Y.;Nakanishi, M.;
Fukuoka, F. Cancer Res. 1969, 29, 734–735;(b) Mizuno,
T. Int. J. Med. Mushrooms 1999, 1, 9–29.